Capital Nasdaq (Taiwan) Market Value

00678 Etf  TWD 28.74  0.64  2.18%   
Capital Nasdaq's market value is the price at which a share of Capital Nasdaq trades on a public exchange. It measures the collective expectations of Capital Nasdaq Biotechnology investors about its performance. Capital Nasdaq is selling for under 28.74 as of the 15th of December 2024; that is 2.18 percent decrease since the beginning of the trading day. The etf's last reported lowest price was 28.7.
With this module, you can estimate the performance of a buy and hold strategy of Capital Nasdaq Biotechnology and determine expected loss or profit from investing in Capital Nasdaq over a given investment horizon. Check out Capital Nasdaq Correlation, Capital Nasdaq Volatility and Capital Nasdaq Alpha and Beta module to complement your research on Capital Nasdaq.
Symbol

Please note, there is a significant difference between Capital Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Capital Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Capital Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Capital Nasdaq 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Capital Nasdaq's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Capital Nasdaq.
0.00
11/15/2024
No Change 0.00  0.0 
In 31 days
12/15/2024
0.00
If you would invest  0.00  in Capital Nasdaq on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Capital Nasdaq Biotechnology or generate 0.0% return on investment in Capital Nasdaq over 30 days. Capital Nasdaq is related to or competes with YuantaP Shares, Yuanta Daily, Yuanta Daily, Fubon FTSE, Fuh Hwa, Paradigm, and Yuanta Daily. CAPITAL SECURITIES is traded on Taiwan Stock Exchange in Taiwan. More

Capital Nasdaq Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Capital Nasdaq's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Capital Nasdaq Biotechnology upside and downside potential and time the market with a certain degree of confidence.

Capital Nasdaq Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Capital Nasdaq's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Capital Nasdaq's standard deviation. In reality, there are many statistical measures that can use Capital Nasdaq historical prices to predict the future Capital Nasdaq's volatility.
Hype
Prediction
LowEstimatedHigh
27.6528.7429.83
Details
Intrinsic
Valuation
LowRealHigh
27.8828.9730.06
Details
Naive
Forecast
LowNextHigh
27.6228.7129.80
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
28.6529.3630.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Capital Nasdaq. Your research has to be compared to or analyzed against Capital Nasdaq's peers to derive any actionable benefits. When done correctly, Capital Nasdaq's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Capital Nasdaq Biote.

Capital Nasdaq Biote Backtested Returns

Capital Nasdaq Biote secures Sharpe Ratio (or Efficiency) of -0.1, which signifies that the etf had a -0.1% return per unit of risk over the last 3 months. Capital Nasdaq Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Capital Nasdaq's Risk Adjusted Performance of (0.05), standard deviation of 1.09, and Mean Deviation of 0.7992 to double-check the risk estimate we provide. The etf shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Capital Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding Capital Nasdaq is expected to be smaller as well.

Auto-correlation

    
  -0.45  

Modest reverse predictability

Capital Nasdaq Biotechnology has modest reverse predictability. Overlapping area represents the amount of predictability between Capital Nasdaq time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Capital Nasdaq Biote price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Capital Nasdaq price fluctuation can be explain by its past prices.
Correlation Coefficient-0.45
Spearman Rank Test-0.54
Residual Average0.0
Price Variance0.13

Capital Nasdaq Biote lagged returns against current returns

Autocorrelation, which is Capital Nasdaq etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Capital Nasdaq's etf expected returns. We can calculate the autocorrelation of Capital Nasdaq returns to help us make a trade decision. For example, suppose you find that Capital Nasdaq has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Capital Nasdaq regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Capital Nasdaq etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Capital Nasdaq etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Capital Nasdaq etf over time.
   Current vs Lagged Prices   
       Timeline  

Capital Nasdaq Lagged Returns

When evaluating Capital Nasdaq's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Capital Nasdaq etf have on its future price. Capital Nasdaq autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Capital Nasdaq autocorrelation shows the relationship between Capital Nasdaq etf current value and its past values and can show if there is a momentum factor associated with investing in Capital Nasdaq Biotechnology.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Capital Etf

Capital Nasdaq financial ratios help investors to determine whether Capital Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Capital with respect to the benefits of owning Capital Nasdaq security.